Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Amortizatization of Intangibles (2016 - 2019)

Historic Amortizatization of Intangibles for Ocular Therapeutix (OCUL) over the last 4 years, with Q2 2019 value amounting to $143000.0.

  • Ocular Therapeutix's Amortizatization of Intangibles changed N/A to $143000.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $330000.0, marking a year-over-year change of. This contributed to the annual value of $17000.0 for FY2017, which is 9086.02% down from last year.
  • As of Q2 2019, Ocular Therapeutix's Amortizatization of Intangibles stood at $143000.0.
  • Ocular Therapeutix's 5-year Amortizatization of Intangibles high stood at $470000.0 for Q4 2015, and its period low was -$148000.0 during Q3 2015.
  • Its 4-year average for Amortizatization of Intangibles is $68000.0, with a median of $16500.0 in 2016.
  • Within the past 5 years, the most significant YoY rise in Ocular Therapeutix's Amortizatization of Intangibles was 67777.78% (2016), while the steepest drop was 9723.4% (2016).
  • Over the past 4 years, Ocular Therapeutix's Amortizatization of Intangibles (Quarter) stood at $470000.0 in 2015, then plummeted by 97.23% to $13000.0 in 2016, then crashed by 53.85% to $6000.0 in 2017, then soared by 2283.33% to $143000.0 in 2019.
  • Its Amortizatization of Intangibles stands at $143000.0 for Q2 2019, versus $187000.0 for Q1 2019 and $6000.0 for Q2 2017.